These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7796959

  • 1. An overview of vaccine vectors.
    Dorner F.
    Dev Biol Stand; 1995; 84():23-32. PubMed ID: 7796959
    [No Abstract] [Full Text] [Related]

  • 2. Salmonellae as oral vaccine carriers.
    Schödel F, Curtiss R.
    Dev Biol Stand; 1995; 84():245-53. PubMed ID: 7796961
    [No Abstract] [Full Text] [Related]

  • 3. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
    Paoletti E, Taylor J, Meignier B, Meric C, Tartaglia J.
    Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
    [Abstract] [Full Text] [Related]

  • 4. Recent advances with recombinant bacterial vaccine vectors.
    Shata MT, Stevceva L, Agwale S, Lewis GK, Hone DM.
    Mol Med Today; 2000 Feb; 6(2):66-71. PubMed ID: 10652479
    [Abstract] [Full Text] [Related]

  • 5. Old microbes with new faces: molecular biology and the design of new vaccines.
    Connell N, Stover CK, Jacobs WR.
    Curr Opin Immunol; 1992 Aug; 4(4):442-8. PubMed ID: 1388846
    [Abstract] [Full Text] [Related]

  • 6. Live bacterial delivery systems for development of mucosal vaccines.
    Thole JE, van Dalen PJ, Havenith CE, Pouwels PH, Seegers JF, Tielen FD, van der Zee MD, Zegers ND, Shaw M.
    Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transgenic plants as vaccine production systems.
    Mason HS, Arntzen CJ.
    Trends Biotechnol; 1995 Sep; 13(9):388-92. PubMed ID: 7546570
    [Abstract] [Full Text] [Related]

  • 10. Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccine.
    Lugosi L.
    Dev Biol Stand; 1992 Sep; 77():211-5. PubMed ID: 1426664
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assuring the quality and safety of vaccines: regulatory licensing and batch release.
    Griffiths E, Knezevic I.
    Methods Mol Med; 2003 Sep; 87():353-76. PubMed ID: 12958467
    [No Abstract] [Full Text] [Related]

  • 13. Experience with veterinary vaccines in warm climates.
    Tulasne JJ, Lefèvre PC, Blancou J.
    Dev Biol Stand; 1996 Sep; 87():33-42. PubMed ID: 8854000
    [Abstract] [Full Text] [Related]

  • 14. Recombinant Salmonella vectors in vaccine development.
    Curtiss R, Kelly SM, Tinge SA, Tacket CO, Levine MM, Srinivasan J, Koopman M.
    Dev Biol Stand; 1994 Sep; 82():23-33. PubMed ID: 7958478
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The current status of Helicobacter pylori vaccines: a review.
    Kabir S.
    Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
    [Abstract] [Full Text] [Related]

  • 20. Bacterial infectious disease control by vaccine development.
    Curtiss R.
    J Clin Invest; 2002 Oct; 110(8):1061-6. PubMed ID: 12393839
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.